Vnitr Lek 2021, 67(2):85-91 | DOI: 10.36290/vnl.2021.019

Diagnostics and therapy of chronic pancreatitis according to UEG guidelines

Lumír Kunovský1,2,3, Petr Dítě1,4,5, Martina Bojková4,5, Jiří Dolina1,3, Jitka Vaculová1,3, Hana Kolovratníková1,3, Magdalena Uvírová6, Pavel Janeček2,3, Zdeněk Kala2,3, Petr Jabandžiev3,7,8
1 Interní gastroenterologická klinika, Fakultní nemocnice Brno
2 Chirurgická klinika, Fakultní nemocnice Brno
3 Lékařská fakulta Masarykovy univerzity, Brno
4 Interní klinika, Fakultní nemocnice Ostrava
5 Lékařská fakulta Ostravské univerzity, Ostrava
6 CGB Laboratoř Ostrava
7 Pediatrická klinika, Fakultní nemocnice Brno
8 Středoevropský technologický institut (CEITEC), Masarykova univerzita, Brno

Chronic pancreatitis is one of the diseases whose incidence is slightly increasing long-term. Apparently this is related to our current dietary habits and to the way of life in industrialized societies in general. In recent years, chronic pancreatitis has experienced greater diagnostic accuracy and reliability, although we are still unable to diagnose the early stages of the disease. In diagnostics, sophisticated imaging methods are in the forefront, and less frequent is the use of tests that assess the exocrine function of the gland. Non-invasive therapeutic approaches include dietary measures, including an absolute ban on alcohol. Drug therapy consists of the application of drugs containing pancreatic digestive enzymes and the treatment of pancreatic pain. The administration of capsules containing microparticles containing pancreatic enzymes, protected against inactivation of enzymes in an acidic gastric environment, is effective. In the treatment of pancreatic pain, we use a range of analgesic drugs, but abstinence from alcohol itself leads to a decrease in the frequency of pancreatic pain. Surgical therapy is very effective. Among other treatment methods include also endoscopic therapy. From the point of view of diagnosis and therapy, chronic pancreatitis is one of the conditions requiring a multidisciplinary approach. In this review article, we discuss the possibilities of diagnosis and treatment of chronic pancreatitis according to the current recommendations of UEG (United European Gastroenterology).

Keywords: chronic pancreatitis, TIGAR‑O classification, pancreas, exocrine pancreatic insufficiency, pancreatic pain, United European Gastroenterology.

Published: April 21, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kunovský L, Dítě P, Bojková M, Dolina J, Vaculová J, Kolovratníková H, et al.. Diagnostics and therapy of chronic pancreatitis according to UEG guidelines. Vnitr Lek. 2021;67(2):85-91. doi: 10.36290/vnl.2021.019.
Download citation

References

  1. Dítě P, Starý K, Novotný I et al. The Incidence of chronic pancreatitis in the Czech Republic. Eur J Gastroenterol Hepatol 2001; 13(6): 749-750. Go to original source... Go to PubMed...
  2. Yadav D, Timmons L, Benson JT et al. Incidence, prevalence and survival of chronic pancreatitis: a population‑based study. Am J Gastroenterol 2011; 106: 2192-2199. Go to original source...
  3. Lévy P, Domínguez‑Muñoz E, Imrie C et al. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United European Gastroenterol J 2014; 2(5): 345-354. Go to original source... Go to PubMed...
  4. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-1261. Go to original source... Go to PubMed...
  5. Kleeff J, Whitcomb D, Shimosegawa T et al. Chronic pancreatitis. Nature Rev Dis Primers 2017; 3: 17060. Go to original source... Go to PubMed...
  6. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification and new genetic developments. Gastroenterology 2001; 120: 682-707. Go to original source... Go to PubMed...
  7. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995; 332: 1482-1490. Go to original source... Go to PubMed...
  8. Whitcomb DC, Frulloni L, Garg P et al. An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016; 16: 218-224. Go to original source... Go to PubMed...
  9. Bojková M, Dítě P, Kunovský L, et al. The role of metabolic syndrome in the induction of chronic pancreatitis after a first attack of acute pancreatitis -multicenter trial. Vnitř Lék 2020; 66(8): e12-e16. Go to original source...
  10. Bertilsson S, Sward P, Kalaitzakis E. Factors that affect disease progression after first attack of acute pancreatitis. Clinical Gastroenterology and Hepatology 2015; 13: 1662-1669. Go to original source... Go to PubMed...
  11. Ahmed Ali U, Issa Y, Hagenaars JC et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol Hepatol 2016; 14(5): 738-746. Go to original source... Go to PubMed...
  12. Hoffmeister A, Mayerle J, Beglinger C et al. Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastroenterol 2015; 53: 1443-1495. Go to original source... Go to PubMed...
  13. Löhr JM, Dominguez‑Munoz E, Rosendahl J et al. United European Gastroenterology evidence - based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol Journal 2017; 5(2): 153-199. Go to original source... Go to PubMed...
  14. Shmulewitz A, Teefey SA, Robinson BS et al. Factor affecting image quality and diagnostic efficacy in abdominal sonography: a prospective study of 140 patients. J Clin Ultrasound 1993; 21: 623-630. Go to original source... Go to PubMed...
  15. Perez‑Johnston R, Sainani NI, Sahani DV. Imaging of chronic pancreatitis (including groove and autoimmune pancreatitis). Radiol Clin North Am 2012; 50: 447-466. Go to original source... Go to PubMed...
  16. Anderson SW, Sato JA. Pancreatic duct evaluation: accuracy of portal venous phase 64 MDCT. Abdominal Imaging 2009; 34: 55-64. Go to original source... Go to PubMed...
  17. Dimastromatteo J, Brentnall T, Kelly K. Imaging in pancreatic disease Nature Reviews Gastroenterol Hepatol 2017; 14: 97-109. Go to original source... Go to PubMed...
  18. Sandrasegaran K, Lin C, Akisik FM. et al. State - of‑the‑art pancreatic MRI. AJR Am J Roentgenol 2010; 195: 42-53. Go to original source... Go to PubMed...
  19. Kim T, Murakami T, Takamura M et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 2001; 177(2): 367-371. Go to original source... Go to PubMed...
  20. Catalano MF, Sahai A, Levy M et al. EUS‑based criteria for the diagnosis of chronic pancreatits. The Rosemont classification. Gastrointest Endosc 2009; 69: 1251-1261. Go to original source... Go to PubMed...
  21. Iglesias‑García J, Lariño‑Noia J, Lindkvist B et al. Endoscopic ultrasound in the diagnosis of chronic pancreatitis. Rev Esp Enferm Dig 2015; 107(4): 221-228. Go to PubMed...
  22. Shi Y, Glaser KJ, Venkatesh SK et al. Feasibility usinig 3D MR elastography to determine pancreatic stiffness in healthy volunteers. J Magn Reson Imaging. 2015; 41: 369-375. Go to original source... Go to PubMed...
  23. Tirkes T, Lin C, Fogel EL et al. T1 mapping for the diagnosis of mild chronic pancreatitis. J Magn Reson Imaging. 2017; 45: 1171-1176. Go to original source... Go to PubMed...
  24. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, Lin JA, Rydberg M. Assessment of chronic pancreatitis: utility of diffusion‑weighted MR imaging with secretin enhancement. Radiology 2009; 250(1): 103-109. Go to original source... Go to PubMed...
  25. Rebours V, Boutron‑Ruault MC, Schnee M et al. The natural history of hereditary pancreatitis: a national series. Gut 2009; 58: 97-103. Go to original source... Go to PubMed...
  26. Németh BC, Sahin‑Tóth M. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014; 306: 466-473. Go to original source... Go to PubMed...
  27. Masson E, Chen JM, Scotet V et al. Association of rare chymotrypsinogen C(CTRC) gene variations in patients with idiopathic chronic pancreatitis. Human Genetics 2008; 123: 83-91. Go to original source... Go to PubMed...
  28. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005; 54Suppl 6: vi1-vi28. Go to original source... Go to PubMed...
  29. Löhr JM. Exocrine pancreatic insufficiency. Uni‑Med Verlag AG 2010. ISBN: 978-3895992025.
  30. Přecechtělová M, Dítě P, Soška V et al. Změny plazmatických hladin vitaminů C a E a volných kyslíkových radikálů u nemocných s chronickou pankreatitidou. Čes a Slov Gastroent 1994; 48 (2): 47-51.
  31. Pezzilli R, Andriulli A, Bassi C et al. Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol 2013; 19(44): 7930-7946. Go to original source... Go to PubMed...
  32. Domínguez‑Muñoz JE, Drewes AM, Lindkvist B et al. Recommendations from United European Gastronterology evidence‑based guidelines for diagnosis and therapy of chronic pancreatitis. Pancreatology 2018; 18: 847-854. Go to original source... Go to PubMed...
  33. Iglesia D, Avci B, Kiriukova M et al. Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‑analysis. United European Gastroenterol Journal 2020; 8(9): 1115-1125. Go to original source... Go to PubMed...
  34. Chaudhary A, Domínguez‑Muñoz JE, Layer P et al. Pancreatic exocrine insufficiency as a complication of gastrointestinal surgery and the impact of pancreatic enzyme replacement therapy. Dig Dis 2020; 38: 53-68. Go to original source... Go to PubMed...
  35. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH‑sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 1983; 84: 476-482. Go to original source...
  36. Warshaw AL, Banks PA, Fernándéz‑Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998; 115: 765-776. Go to original source... Go to PubMed...
  37. Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol and Ther 2016; 7(3): 370-386. Go to original source... Go to PubMed...
  38. Pitchumoni CS. Chronic pancreatitis: pathogenesis and management of pain. J Clin Gastroenterol 1998; 27: 101-107. Go to original source... Go to PubMed...
  39. Enweluzo C, Tlhabano L. Pain management in chronic pancreatitis: taming the beast. Clin Exp Gastroenterol 2013; 6: 167-171. Go to original source... Go to PubMed...
  40. Talukdar R, Murthy HM, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review. Pancreatology. 2015; 15: 136-144. Go to original source... Go to PubMed...
  41. Winstead NS, Wilcox CM. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis--a review. Pancreatology 2009; 9: 344-350. Go to original source... Go to PubMed...
  42. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983; 28: 97-102. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.